Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
HK Stock Market Move | 3SBIO (01530) is now up more than 6%, Pfizer has identified 707 as a core pipeline and plans to initiate multiple clinical studies.
HK Stock Market Move | JOHNSON ELEC H(00179) fell more than 11%, with a 1% year-on-year decrease in mid-term revenue and a 3% increase in net profit.
Behind the trillion yuan sales of the "Double Eleven" grand promotion, Hong Kong stocks consumer and technology sectors are "waiting for the wind to come".
HK Stock Market Move | 3SBIO (01530) is now up more than 6%, Pfizer has identified 707 as a core pipeline and plans to initiate multiple clinical studies.
HK Stock Market Move | JOHNSON ELEC H(00179) fell more than 11%, with a 1% year-on-year decrease in mid-term revenue and a 3% increase in net profit.
Behind the trillion yuan sales of the "Double Eleven" grand promotion, Hong Kong stocks consumer and technology sectors are "waiting for the wind to come".
RECOMMEND
Younger consumers are dining out less at Chipotle and Cava while still buying Coach handbags
10/11/2025
Target’s deteriorating in-store experience risks recovery — retailer bets on a refined fulfillment model to fix it
10/11/2025
China suspends approval ban on exports of certain metals used in chip and electronics manufacturing to the U.S.
10/11/2025
